Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

1 Undervalued Generic Producer and 1 Peer Stock With Momentum
Motley Fool
Thursday, January 24, 2013 - 10:27am
tags:
generics, Mylan, Teva
Cubist Pharma Earnings: A Mixed Reaction to Analyst Estimates
Wall St. Cheat Sheet
Thursday, January 24, 2013 - 10:27am
tags:
earnings, Cubist Pharmaceuticals
AstraZeneca: Results Preview
Motley Fool
Thursday, January 24, 2013 - 10:25am
tags:
earnings, Astra Zeneca
Bristol-Myers beats forecasts, as newer drugs deliver
Reuters
Thursday, January 24, 2013 - 10:23am
tags:
earnings, Bristol-Myers Squibb
This Is the Most Exciting IPO of the Year
Motley Fool
Thursday, January 24, 2013 - 9:53am
tags:
IPOs, Zoetis, Pfizer, animal health
Atrial fibrillation: nContact wins FDA clearance for cardiac device
Mass Device
Wednesday, January 23, 2013 - 9:26pm
tags:
atrial fibrillation, FDA, cadiac, devices, regulatory
1 in 3 metal hips may fail in under 5 years, J&J analysis finds
Mass Device
Wednesday, January 23, 2013 - 9:25pm
tags:
hip, implants, patient, Johnson & Johnson, safety, devices
Covidien touts EU win for EverFlex stent
Mass Device
Wednesday, January 23, 2013 - 9:24pm
tags:
Covidien, EU, EverFlex, stent
Allergan drops $958M on migraine drug maker MAP Pharma
Mass Device
Wednesday, January 23, 2013 - 9:24pm
tags:
Allergan, M&A, migraine
Covidien snags CE mark for self-expanding stent
FierceMedicalDevice
Wednesday, January 23, 2013 - 9:14pm
tags:
Covidien, CE Mark, stent
After FDA ban, Hospira creeps back into the infusion game with Q Core deal
FierceMedicalDevice
Wednesday, January 23, 2013 - 9:14pm
tags:
FDA, Hospira, infusion
Abbott faces lagging stent sales in drug-free future
FierceMedicalDevice
Wednesday, January 23, 2013 - 9:13pm
tags:
Abbott Laboratories, stent, sales, devices
St. Jude Medical Reports Fourth Quarter and Full-Year 2012 Results
Yahoo/BusinessWire
Wednesday, January 23, 2013 - 9:09pm
tags:
St. Jude Medical, earnings, devices
Intuitive Surgical rises 9 pct. on strong earnings
Yahoo/AP
Wednesday, January 23, 2013 - 9:07pm
tags:
Intuitive Surgical, stock, earnings, devices
Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2013
Yahoo/PRNewswire
Wednesday, January 23, 2013 - 9:05pm
tags:
Varian Medical, earnings, devices
Stryker Reports Fourth Quarter and Full Year 2012 Results
Yahoo/Reuters
Wednesday, January 23, 2013 - 9:04pm
tags:
Stryker, earnings, M&A, devices
OPKO Announces Proposed Private Offering of $150 Million Convertible Senior Notes Due 2033
Yahoo/BusinessWire
Wednesday, January 23, 2013 - 9:03pm
tags:
OPKO, stock, devices
AngioDynamics to Acquire Microsulis' Leading Microwave Ablation Technology
Yahoo/GlobeNewswire
Wednesday, January 23, 2013 - 8:39pm
tags:
AngioDynamics, Microsulis Medical, microwave ablation
BIOLASE Announces Launch of Occulase Website
Yahoo/MarketWire
Wednesday, January 23, 2013 - 8:38pm
tags:
BIOLASE IMAGING, website, technology
Kips Bay Medical Announces FDA Approval of Additional US Study Patients
Yahoo/BusinessWire
Wednesday, January 23, 2013 - 8:38pm
tags:
Kips Bay Medical, FDA, patient, research, regulatory, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.